In RA, silencing RNA was investigated upon i.v. administration in a murine CIA model, namely through liposomal formulations encapsulating siRNA for TNF-α (ζ: 30–40 mV) or for IL-1β, IL-6 or IL-18, individually. Here, IL6 is linked to rheumatoid arthritis.